Mabion S.A. | |
Stock Exchange | Warsaw Stock Exchange |
EPS |
PLN5.16 |
Market Cap |
PLN1.16 B |
Shares Outstanding |
13.72 M |
Public Float |
7.51 M |
Address |
ul. gen. Mariana Langiewicza 60 Konstantynów Lódzki LD 95 Poland |
Employees | - |
Website | http://www.mabion.eu |
Updated | 07/08/2019 |
Mabion SA is a biotechnology company, which engages in the development and manufacturing of biotech drugs. Its products, which are based on humanized monoclonal antibodies, are used for the treatment of cancer and metabolic diseases. It also involved research in the field of biotechnology. |